Status:
ACTIVE_NOT_RECRUITING
Stroke Prevention and Rhythm Control Therapy STEEER-AF
Lead Sponsor:
European Society of Cardiology
Collaborating Sponsors:
University of Birmingham
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A prospective trial with hospitals/health centres across 6 different European countries, being randomised to either a structured education programme as the intervention or no additional education as t...
Detailed Description
Prospective, parallel group, two-arm, unblinded, international, cluster-randomized controlled trial. Intervention arm: A 16-week blended learning programme targeting stroke prevention and rhythm cont...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients diagnosed with AF
- Patient consents to data collection at baseline and follow-up.
- Exclusion Criteria (patients only):
- Patients aged under 18 years of age,
- Pregnant or planning pregnancy,
- Participating in another clinical trial of an investigational medicinal product or device,
- Life expectancy of less than 2 years.
- Patient assessment: Baseline (time of recruitment) and at follow-up routine appointment (6-9 months), plus remote follow-up at 18 months.
Exclusion
Key Trial Info
Start Date :
December 29 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2025
Estimated Enrollment :
1732 Patients enrolled
Trial Details
Trial ID
NCT04396418
Start Date
December 29 2021
End Date
December 30 2025
Last Update
June 20 2024
Active Locations (70)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Rennes
Rennes, 'Ille-et-Vilaine, Brittany, France, 35000
2
CHU La Timone
Marseille, Bouches-du-Rhône, France, 13005
3
CHU Dijon - Hôpital du Bocage
Dijon, Burgundy, France, 21000
4
Hôpital Cardiologique du Haut-Lévèque
Pessac, Gironde, Nouvelle-Aquitaine, France, 33600